Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Finetti

Showing results (111-120 of 180) with videos related to

Pageof 18
Sort By:
Cancers|July 3, 2020
Enhancement of Breast Cancer Cell Aggressiveness by lncRNA <i>H19</i> and its Mir-675 Derivative: Insight into Shared and Different ActionsEvodie Peperstraete, Clément Lecerf, Jordan Collette, et al.
Communications Biology|August 20, 2021
LDL receptor-peptide conjugate as in vivo tool for specific targeting of pancreatic ductal adenocarcinomaAngélina Acier, Magali Godard, Fanny Gassiot, et al.
Cancer Research|December 3, 2004
Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapyFrançois Bertucci, Pascal Finetti, Jacques Rougemont, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 15, 2022
DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancerThi Khanh Le, Chaïma Cherif, Kenneth Omabe, et al.
Genes, Chromosomes & Cancer|April 11, 2012
Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasmsMandy Brecqueville, Jérôme Rey, François Bertucci, et al.
Neoplasia (New York, N.Y.)|June 14, 2017
Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC)Madhura Joglekar-Javadekar, Steven Van Laere, Michael Bourne, et al.
Breast Cancer Research : BCR|November 3, 2011
Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC-PACS 01 randomized trialJocelyne Jacquemier, Jean-Marie Boher, Henri Roche, et al.
International Journal of Cancer|June 28, 2007
Moesin expression is a marker of basal breast carcinomasEmmanuelle Charafe-Jauffret, Florence Monville, François Bertucci, et al.
BMC Cancer|October 12, 2010
Genome profiling of ERBB2-amplified breast cancersFabrice Sircoulomb, Ismahane Bekhouche, Pascal Finetti, et al.
Oncogene|January 27, 2004
Identification and validation of an ERBB2 gene expression signature in breast cancersFrançois Bertucci, Nathalie Borie, Christophe Ginestier, et al.
Pageof 18

Showing results (111-120 of 180) with videos related to

Sort By:
Pageof 18
Cancers|July 3, 2020
Enhancement of Breast Cancer Cell Aggressiveness by lncRNA <i>H19</i> and its Mir-675 Derivative: Insight into Shared and Different ActionsEvodie Peperstraete, Clément Lecerf, Jordan Collette, et al.
Communications Biology|August 20, 2021
LDL receptor-peptide conjugate as in vivo tool for specific targeting of pancreatic ductal adenocarcinomaAngélina Acier, Magali Godard, Fanny Gassiot, et al.
Cancer Research|December 3, 2004
Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapyFrançois Bertucci, Pascal Finetti, Jacques Rougemont, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 15, 2022
DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancerThi Khanh Le, Chaïma Cherif, Kenneth Omabe, et al.
Genes, Chromosomes & Cancer|April 11, 2012
Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasmsMandy Brecqueville, Jérôme Rey, François Bertucci, et al.
Neoplasia (New York, N.Y.)|June 14, 2017
Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC)Madhura Joglekar-Javadekar, Steven Van Laere, Michael Bourne, et al.
Breast Cancer Research : BCR|November 3, 2011
Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC-PACS 01 randomized trialJocelyne Jacquemier, Jean-Marie Boher, Henri Roche, et al.
International Journal of Cancer|June 28, 2007
Moesin expression is a marker of basal breast carcinomasEmmanuelle Charafe-Jauffret, Florence Monville, François Bertucci, et al.
BMC Cancer|October 12, 2010
Genome profiling of ERBB2-amplified breast cancersFabrice Sircoulomb, Ismahane Bekhouche, Pascal Finetti, et al.
Oncogene|January 27, 2004
Identification and validation of an ERBB2 gene expression signature in breast cancersFrançois Bertucci, Nathalie Borie, Christophe Ginestier, et al.
Pageof 18